These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8947981)

  • 21. Activated clotting time differential is a superior method of monitoring anticoagulation following coronary angioplasty.
    Pitney MR; Kelly SA; Allan RM; Giles RW; McCredie M; Walsh WF
    Cathet Cardiovasc Diagn; 1996 Feb; 37(2):145-50. PubMed ID: 8808069
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Therapeutic infusion of heparin. Application of a nomogram correlated with weight].
    Verdiani V; Morettini A; Nozzoli C; Berni G; Sanzo P
    Recenti Prog Med; 2001 Mar; 92(3):189-92. PubMed ID: 11320849
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of a heparin nomogram for treatment of patients with venous thromboembolism in a community hospital.
    de Groot MR; Büller HR; ten Cate JW; van Marwijk Kooy M
    Thromb Haemost; 1998 Jul; 80(1):70-3. PubMed ID: 9684788
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of the standard pediatric unfractionated heparin dosing protocol.
    Al Obary EE; Al-Jazairi AS; Zaghloul IM; Saleh MM; Al Musa AS; Al-Halees Z
    Asian Cardiovasc Thorac Ann; 2012 Apr; 20(2):153-9. PubMed ID: 22499962
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of 2 weight-based heparin dosing nomograms in neurology and vascular surgical patients.
    Marotti SB; Barras M; Kirkpatrick C
    Ther Drug Monit; 2015 Feb; 37(1):33-9. PubMed ID: 24831654
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of a modified dosing weight for heparin therapy in a morbidly obese patient.
    Schwiesow SJ; Wessell AM; Steyer TE
    Ann Pharmacother; 2005 Apr; 39(4):753-6. PubMed ID: 15741422
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heparin dosage adjustment in patients with deep-vein thrombosis using heparin concentrations rather than activated partial thromboplastin time.
    Groce JB; Gal P; Douglas JB; Steuterman MC
    Clin Pharm; 1987 Mar; 6(3):216-22. PubMed ID: 3665377
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reevaluation of a weight-based heparin dosing nomogram: is institution-specific modification necessary?
    Schlicht JR; Sunyecz L; Weber RJ; Tabas GH; Smith RE
    Ann Pharmacother; 1997 Dec; 31(12):1454-9. PubMed ID: 9416380
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Experience with heparin dosing at Christchurch Hospital.
    Ward ML; Duffull SB
    N Z Med J; 1998 Jun; 111(1068):228-30. PubMed ID: 9695751
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Physician practices in the treatment of pulmonary embolism and deep venous thrombosis.
    Wheeler AP; Jaquiss RD; Newman JH
    Arch Intern Med; 1988 Jun; 148(6):1321-5. PubMed ID: 3377615
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of weight, sex, age, clinical diagnosis, and thromboplastin reagent on steady-state intravenous heparin requirements.
    White RH; Zhou H; Woo L; Mungall D
    Arch Intern Med; 1997 Nov; 157(21):2468-72. PubMed ID: 9385298
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of weight-based dosing of unfractionated heparin in obese children.
    Taylor BN; Bork SJ; Kim S; Moffett BS; Yee DL
    J Pediatr; 2013 Jul; 163(1):150-3. PubMed ID: 23414664
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hemostatic activation under anticoagulant treatment: a comparison of unfractionated heparin vs. nadroparin in the treatment of proximal deep vein thrombosis.
    Stricker H; Marchetti O; Haeberli A; Mombelli G
    Thromb Haemost; 1999 Oct; 82(4):1227-31. PubMed ID: 10544903
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Different effects of heparin in males and females.
    Campbell NR; Hull RD; Brant R; Hogan DB; Pineo GF; Raskob GE
    Clin Invest Med; 1998 Apr; 21(2):71-8. PubMed ID: 9562927
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The weight-based heparin dosing nomogram compared with a "standard care" nomogram. A randomized controlled trial.
    Raschke RA; Reilly BM; Guidry JR; Fontana JR; Srinivas S
    Ann Intern Med; 1993 Nov; 119(9):874-81. PubMed ID: 8214998
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of systemic anticoagulation in patients undergoing angioaccess surgery.
    D'Ayala M; Smith RM; Martone C; Briggs W; Deitch JS; Wise L
    Ann Vasc Surg; 2008 Jan; 22(1):11-5. PubMed ID: 18055171
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of two nomograms of unfractionated heparin in patients with acute coronary syndrome.
    Modares Mosadegh M; Sadr Bafghi SM
    Acta Med Iran; 2013 Mar; 51(2):87-93. PubMed ID: 23585314
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The use and limitations of unfractionated heparin.
    Krishnaswamy A; Lincoff AM; Cannon CP
    Crit Pathw Cardiol; 2010 Mar; 9(1):35-40. PubMed ID: 20215909
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nomograms for the administration of unfractionated heparin in the initial treatment of acute thromboembolism--an overview.
    Bernardi E; Piccioli A; Oliboni G; Zuin R; Girolami A; Prandoni P
    Thromb Haemost; 2000 Jul; 84(1):22-6. PubMed ID: 10928464
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimal dosing of subcutaneous unfractionated heparin for the treatment of deep vein thrombosis.
    Kearon C; Harrison L; Crowther M; Ginsberg JS
    Thromb Res; 2000 Mar; 97(6):395-403. PubMed ID: 10704648
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.